Neoaska Pharma Private Limited - Company Profile

It is a pharma private limited company based in Seri Lingampally, Telangana, India, established in 2017.
2017 Seri Lingampally, Telangana, India Active
Last Updated:
Access Report
About Neoaska Pharma Private Limited

Neoaska Pharma Private Limited, a active private limited company, was established on 10 October 2017 in Seri Lingampally, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74999TG2017PTC119969. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹150.00 Cr and a paid-up capital of ₹23.12 Cr.

Formerly known as Neo Aska Pharma Private Limited, Neumedica Life Sciences Private Limited. It upholds a compliant status. Employing 30 professional, Its leadership includes Nagaraja Rathan Yancharla (Director), Pakanati Venkata Raghava Reddy (Additional Director). Past directors included Suresh Kumar Nandiraju, Kazuhiko Kato, Shireesh Shetty. It holds no open charges and ₹18.96 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Door No 1-66/1/Ceo/1/Ph Plot No 1 Ceo Enclave,, Sy No. 136/2 And 136/4, Gachibowli, Hyderabad,, Seri Lingampally, Telangana, 500032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999TG2017PTC119969

  • Registration Number

    119969

  • Incorporation Date

    10 October 2017

  • Authorized Capital

    ₹150.00 Cr

  • Paid-Up Capital

    ₹23.12 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 150.00 Cr
  • Paid Up Capital ₹ 23.12 Cr
  • Company Age 8 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 18.96 Cr
  • Revenue Growth **** %
  • Profit Growth **** 17240.00%
  • Ebitda **** -20060.00%
  • Net Worth 1834440.00%
  • Total Assets **** 924.26%
Company report

Neoaska Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Neoaska Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Neoaska Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Nagaraja Rathan Yancharla Director 13 Jul 2023 Current
Pakanati Venkata Raghava Reddy Additional Director 01 Dec 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 10 Aug 2020 Past
Pramod Abcsdd Director 30 Dec 2020 Past
Pramod Abcsdd Additional Director 13 Jul 2023 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Director 15 May 2020 Past
Pramod Abcsdd Director 13 Jul 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Neoaska Pharma.

Neoaska Pharma Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 17240% increase in profit. The company's net worth Soared by an impressive increase of 1834440%.

Neoaska Pharma revenue growth over time
Neoaska Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 924.26%
*******
*******
*******
*******
Profit or Loss
*******
 17240.00%
*******
*******
*******
*******
Net Worth
*******
 1834440.00%
*******
*******
*******
*******
EBITDA
*******
 -20060.00%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Neoaska Pharma?

In 2019, Neoaska Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹189,596,588.00

Charges Breakdown by Lending Institutions
  • Others : 18.96 Cr
Latest Charge Details
Date Lender Amount Status
01 Oct 2019 Others ₹18.96 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Neoaska Pharma?

Neoaska Pharma has a workforce of 30 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Neoaska Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neoaska Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Neoaska Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Neoaska Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Neoaska Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Director Appointment

    The activity Pakanati Venkata Raghava Reddy was appointed as a Additional Director was appointed as a Additional Director on 01 Dec 2023 & has been associated with this company since 2 years 3 months . was completed.

  • Charges

    A charge registered on 01 Oct 2019 via Charge ID 100297367 with Others was fully satisfied on 18 Aug 2023. was recorded as a recent event.

  • Director Appointment

    Progress on Nagaraja Rathan Yancharla was appointed as a Director was appointed as a Director on 13 Jul 2023 & has been associated with this company since 2 years 7 months . was documented.

  • Charges

    Progress on A charge with Others of Rs. 18.96 Cr registered on 01 Oct 2019 with Charge ID 100297367 was modified on 18 May 2022. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Neoaska Pharma Private Limited?

The CIN of Neoaska Pharma Private Limited is U74999TG2017PTC119969.

Where is Neoaska Pharma Private Limited headquartered?

Neoaska Pharma Private Limited is headquartered at Door No 1-66/1/Ceo/1/Ph Plot No 1 Ceo Enclave,, Sy No. 136/2 And 136/4, Gachibowli, Hyderabad,, Seri Lingampally, Telangana, 500032.

When was Neoaska Pharma Private Limited incorporated?

Neoaska Pharma Private Limited was incorporated on 10 October 2017.

Who are the current directors of Neoaska Pharma Private Limited?

The current directors of Neoaska Pharma Private Limited are

What is the primary industry of Neoaska Pharma Private Limited?

The primary industry of Neoaska Pharma Private Limited is Pharma.

Is Neoaska Pharma Private Limited a listed company?

Neoaska Pharma Private Limited is unlisted.

What is the capital structure of Neoaska Pharma Private Limited?

The authorized capital of Neoaska Pharma Private Limited is ₹150.00 Cr, and the paid-up capital is ₹23.12 Cr.

What is the compliance status of Neoaska Pharma Private Limited?

The compliance status of Neoaska Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available